Ligand Pharmaceuticals

Spotlight – What is next in Nash
Spotlight – What is next in Nash
EP Vantage
NASH
clinical trials
89Bio
Arrowhead Pharmaceuticals
Can-Fite BioPharma
Ewopharma
Hepagene Therapeutics
JNJ
Ligand Pharmaceuticals
Madrigal Pharmaceuticals
Merck
NGM Biopharmaceuticals
NorthSea Therapeutics
Novartis
Sagimet Biosciences
Terns Pharmaceuticals
Viking Therapeutics
Flag link:
Drug discovery specialists at Ligand take their antibody biz public via SPAC, aiming to build $850M company
Drug discovery specialists at Ligand take their antibody biz public via SPAC, aiming to build $850M company
Endpoints
Ligand Pharmaceuticals
drug discovery
OmniAb
SPACs
Flag link:
Ligand to split in half, spinning OmniAb platform into its own company
Ligand to split in half, spinning OmniAb platform into its own company
Endpoints
Ligand Pharmaceuticals
OmniAb
antibody discovery
drug discovery
spinoffs
Flag link:
Ligand snags Roche-partnered drug in Icagen buyout
Ligand snags Roche-partnered drug in Icagen buyout
Fierce Biotech
Ligand Pharmaceuticals
Roche
Icagen
M&A
Flag link:
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
Flag link:
Ligand acquires Ab Initio Biotherapeutics, an antigen-discovery company
Ligand acquires Ab Initio Biotherapeutics, an antigen-discovery company
Pharmaceutical Business Review
Ligand Pharmaceuticals
Ab Initio Biotherapeutics
M&A
Flag link:
Ligand acquires milestone and royalty rights to SB206 from Novan
Ligand acquires milestone and royalty rights to SB206 from Novan
Pharmaceutical Business Review
Ligand Pharmaceuticals
Novan
SB206
skin infections
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
Flag link:
With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence
With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence
Xconomy
Ligand Pharmaceuticals
Vernalis
M&A
Flag link:
5 Top Biotech Stocks
5 Top Biotech Stocks
Motley Fool
biotech
AbbVie
Celgene
Gilead Sciences
Ligand Pharmaceuticals
Vertex Pharmaceuticals
Flag link:
3 Small, Profitable Biotechs With Fantastic Growth
3 Small, Profitable Biotechs With Fantastic Growth
Motley Fool
biotech
Corcept Therapeutics
ANI Pharmaceuticals
Ligand Pharmaceuticals
Flag link:
3 Biotechs With Tremendously Promising Pipelines
3 Biotechs With Tremendously Promising Pipelines
Motley Fool
biotech
Celgene
Ionis
Ligand Pharmaceuticals
Flag link:
Ligand reports 2Q loss
Ligand reports 2Q loss
Yahoo/AP
Ligand Pharmaceuticals
earnings
Flag link:
Ligand Pharmaceuticals Q1 Adjusted Earnings Beat
Ligand Pharmaceuticals Q1 Adjusted Earnings Beat
Yahoo/Benzinga
Ligand Pharmaceuticals
earnings
Flag link:
Ligand Pharmaceuticals posts 4Q profit of $6.3 million, result tops expectations
Ligand Pharmaceuticals posts 4Q profit of $6.3 million, result tops expectations
Yahoo/AP
Ligand Pharmaceuticals
earnings
Flag link:
Who Could Be Allergan PLC Next Acquisition Target?
Who Could Be Allergan PLC Next Acquisition Target?
Bidness, ETC
Allergan
M&A
Pfenex
Ligand Pharmaceuticals
Ardelyx
Flag link:
Ligand posts 2Q profit
Ligand posts 2Q profit
Yahoo/AP
Ligand Pharmaceuticals
earnings
Flag link:
3 Biotech Stocks That Could Grow Faster than Apple
3 Biotech Stocks That Could Grow Faster than Apple
Motley Fool
biotech
Celgene
Medivation
Ligand Pharmaceuticals
Flag link:
Ligand Pharmaceuticals posts 1Q profit, results beat Street expectations
Ligand Pharmaceuticals posts 1Q profit, results beat Street expectations
Yahoo/AP
Ligand Pharmaceuticals
earnings
Flag link:
Biotech Ligand Gets Sweeter Deal From Partner Viking
Biotech Ligand Gets Sweeter Deal From Partner Viking
Investors.com
Ligand Pharmaceuticals
Viking Therapeutics
IPOs
Flag link:

Pages